ArticleCureus2023

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study.

Suhas Erande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.